Search results for: 'oral market'

This analysis provides an overview and advancements in the oral solid dosage formulation industry, including an evaluation of the current industry scenario, competitive landscape, and regulatory landscape. The scope of the analysis is global, focusing on North America (NA), Europe, Asia-Pacific (APAC), the Middle East, and Latin America (LATAM). It...

Excipients have been a part of the pharmaceutical industry and their demand is expected to increase during the forecast period. This is owing to their ability to perform various functions such as improving the stability of the active pharmaceutical ingredient (API), modifying drug release, and masking taste. Expanding patient base coupled with the ...

Frost & Sullivan’s analysis of the oral solid dosage excipients market aims at quantifying the consumption and analyzing the impact of key disruptive, transformative, and competitive trends across the value chain order to present a forecast for the eight year period of 2022 to 2030. The scope of the study comprises analysis of the oral solid dosage...

Excipients are used to support the delivery of the APIs (active pharmaceutical ingredients) through oral dosage, parenteral, and transdermal medications. For oral dosages, the key delivery forms are tablets and capsules. This research service covers the North American oral solid drug dosage excipients market. Based on functionality, excipients are ...

This market insight provides data for the global multiple sclerosis (MS) market. The analysis looks at MS pharmaceutical pipeline drugs that are currently in the market as well as any drugs that are in Phase III trials and pose a potential threat to competitors. It offers a competitive analysis of these drugs and the forecasted outcome and impact o...

This market insight discusses the rheumatoid arthritis pharmaceutical drugs currently in the global market as well as those in the development stage. It offers a competitive analysis of the drugs and a forecast of their impact on the market. Drugs in the development stage are segmented by clinical trial phase as well as by drug class. The study cov...

Temporomandibular Disorder (TMD) is a complex condition that affects the temporomandibular joint (TMJ), the joint connecting the lower jaw to the skull. About 50% of the patient population receiving treatment for TMD complains of pain after 5 years of treatment, and about 20% of the population experiences long-term disability. Estimated annual heal...

This Frost & Sullivan report analyzes the global pharmaceutical excipients market, with a focus on key regional markets, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa (MEA). The report provides both qualitative and quantitative analyses of various segments, including oral dosage excipients, injectable ...

14 Sep 2022  |  Global  |  Market Research

Global Medical Food Growth Opportunities

Collaborative Efforts Between Drug Manufacturers and Medical Food Manufacturers to Boost Growth Opportunities for Medical Food

Infographics

×

Key Benefits

The US FDA defines medical food as “a food, which is formulated to be consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evalua...